Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Team Preop Briefing Improves Communication, Reduces Errors
A short, preoperative team briefing prior to cardiac surgery - where each person on the team speaks - improves communication and reduces errors and costs, according to a pilot study conducted at Mayo Clinic.
generic viagra online
Also In Global Health News: HIV & TB; ITN Program; DRC's Health System
HIV-Positive Babies More Likely To Contract Deadly TB If Given BCG
News of the day
Vietnamese HIV/AIDS Department Announces Funding For Prevention Efforts
Vietnamese officials announced recently that about 678 billion dong, or about $38.7 million, will be allocated for HIV/AIDS prevention efforts in the country in 2009, the VNA/VietnamPlus.com reports. The announcement was made during a press briefing earlier this week held by the Department for HIV/AIDS Prevention and the Vietnam Journalists Association to review Vietnam"s HIV/AIDS efforts in 2008. Health officials at the briefing said that more than 27,000 people living with HIV/AIDS received treatment through one of the 207 district-level clinics put in place last year and that about 6,000 peer educators and health workers distributed information about the disease to 53.8% of the country"s districts.The new funding will help provide antiretroviral treatment to an estimated 32,000 people living with HIV/AIDS. It also will be used to provide post-exposure prophylaxis to health workers. In addition, the funding will allow up to 90% of HIV-positive pregnant women to receive antiretroviral treatment and information about preventing mother-to-child transmission. Last year, 20,260 new HIV cases were reported in Vietnam, of which 7,452 had progressed to AIDS, according to the HIV/AIDS department. The city of Ho Chi Minh reported the largest number of HIV cases with more than 34,000, accounting for more than 25% of the total number of cases in Vietnam (VNA/VietnamPlus.com, 5/12).
Nutrition

Sepracor Pharmaceuticals Ltd Withdraws Its Marketing Authorisation Application For Lunivia (eszopiclone)

The European Medicines Agency has been formally notified by Sepracor Pharmaceuticals Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Lunivia (eszopiclone), 2 and 3 mg tablets. Lunivia was expected to be used for the treatment of insomnia, including difficulty falling asleep, nocturnal awakening or early awakening in adults, usually for short-term duration. The application for the marketing authorisation for Lunivia was submitted to the Agency on 23 July 2007. In October 2008, Lunivia received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), recommending that the medicine be granted a marketing authorisation. However, the CHMP recommended that the medicine should not be granted "new active substance" status. Following a re÷¬examination procedure at the request of the applicant, the CHMP confirmed its previous opinion in February 2009. At the time of withdrawal, the application was pending the adoption of a marketing authorisation decision by the European Commission. In its official letter, the company stated that the withdrawal of the application was based on the CHMP"s recommendation that Lunivia should not be regarded as containing a new active substance, and that the commercial viability of launching the product in the European Union was compromised. More information about Lunivia and the state of the scientific assessment at the time of withdrawal will be made available in a question-and-answer document. This document, together with the withdrawal letter from the company, will be published on the Agency"s website after the next CHMP meeting of 26-29 May 2009. Notes 1. Withdrawal of an application does not prejudice the possibility of a company making a new application at a later stage. 2. The press release from the October 2008 meeting can be found here. 3. The summary of the positive opinion from October 2008 can be found here. EMEA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009